◆英語タイトル:pSivida Corp (PSDV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011389
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月22日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. pSivida’s iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company offers drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. It operates in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.
pSivida Corp (PSDV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
pSivida Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
pSivida Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
pSivida Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
pSivida Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
pSivida Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
pSivida Corp, Medical Equipment, Deal Details 10
Partnerships 10
Alimera Sciences Enters into Licensing Agreement with pSivida 10
pSivida Amends Licensing Agreement With Pfizer 11
Equity Offering 12
pSivida Plans to Raise Upto USD20 Million in Public Offering of Shares 12
pSivida Raises USD17.8 Million in Public Offering of Shares 13
pSivida Raises USD7 Million in Private Placement of Shares 15
pSivida Announces Private Placement Of Shares For US$19 Million 16
pSivida Completes Public Offering Of Shares For US$10.8 Million 17
pSivida Completes Private Placement Of Units For US$5.4 Million 18
pSivida Completes Registered Direct Offering Of Units For US$11 Million 19
pSivida Corp – Key Competitors 21
pSivida Corp – Key Employees 22
pSivida Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Nov 07, 2017: pSivida Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution 24
Sep 11, 2017: pSivida Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results 25
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track 26
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results 27
Feb 07, 2017: pSivida Reports Fiscal 2017 Second Quarter and First Half Results 28
Nov 07, 2016: pSivida Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives & Milestone Timeline 30
Sep 12, 2016: PSIVIDA Provides Company Update And Reports Fourth Quarter And FY 2016 Results 32
Feb 08, 2016: Psivida Provides Company Update And Reports Second Quarter FY 201 6 Results 34
Corporate Communications 36
Jun 28, 2017: pSivida Enhances Board of Directors with Election of Veteran Healthcare Executive Kristine Peterson 36
Dec 07, 2016: Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial Development 37
Sep 27, 2016: pSivida Strengthens Board of Directors With Leading Ophthalmologist 38
Aug 03, 2016: pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer 39
Product News 40
Aug 29, 2016: pSivida Announces 13 New Patents Issued or Allowed 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
pSivida Corp, Medical Equipment, Key Facts, 2017 2
pSivida Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
pSivida Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
pSivida Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
pSivida Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
pSivida Corp, Deals By Market, 2011 to YTD 2017 8
pSivida Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Alimera Sciences Enters into Licensing Agreement with pSivida 10
pSivida Amends Licensing Agreement With Pfizer 11
pSivida Plans to Raise Upto USD20 Million in Public Offering of Shares 12
pSivida Raises USD17.8 Million in Public Offering of Shares 13
pSivida Raises USD7 Million in Private Placement of Shares 15
pSivida Announces Private Placement Of Shares For US$19 Million 16
pSivida Completes Public Offering Of Shares For US$10.8 Million 17
pSivida Completes Private Placement Of Units For US$5.4 Million 18
pSivida Completes Registered Direct Offering Of Units For US$11 Million 19
pSivida Corp, Key Competitors 21
pSivida Corp, Key Employees 22
pSivida Corp, Subsidiaries 23